Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 22;81(17):1531-7.
doi: 10.1212/WNL.0b013e3182a95818. Epub 2013 Sep 25.

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study

Affiliations

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study

Hongliu Ding et al. Neurology. .

Abstract

Objective: To conclusively test for a specific association between the biological marker 25-hydroxy-vitamin D3, a transcriptionally active hormone produced in human skin and liver, and the prevalence and severity of Parkinson disease (PD).

Methods: We used liquid chromatography/tandem mass spectrometry to establish an association specifically between deficiency of 25-hydroxy-vitamin D3 and PD in a cross-sectional and longitudinal case-control study of 388 patients (mean Hoehn and Yahr stage of 2.1 ± 0.6) and 283 control subjects free of neurologic disease nested in the Harvard Biomarker Study.

Results: Plasma levels of 25-hydroxy-vitamin D3 were associated with PD in both univariate and multivariate analyses with p values = 0.0034 and 0.047, respectively. Total 25-hydroxy-vitamin D levels, the traditional composite measure of endogenous and exogenous vitamin D, were deficient in 17.6% of patients with PD compared with 9.3% of controls. Low 25-hydroxy-vitamin D3 as well as total 25-hydroxy-vitamin D levels were correlated with higher total Unified Parkinson's Disease Rating Scale scores at baseline and during follow-up.

Conclusions: Our study reveals an association between 25-hydroxy-vitamin D3 and PD and suggests that thousands of patients with PD in North America alone may be vitamin D-deficient. This finding has immediate relevance for individual patients at risk of falls as well as public health, and warrants further investigation into the mechanism underlying this association.

PubMed Disclaimer

Figures

Figure
Figure. Plasma levels of 25[OH]D3 and total 25[OH]D in PD
Relations between 25[OH]D3 (upper panels) or total 25[OH]D plasma levels (lower panels) and PD, HY stage (<3 or ≥3), total UPDRS score, and disease duration are visualized. Raw data are visualized, curves in the scatter plots are fitted by Lowess regression, and p values from the corresponding multivariate analyses adjusted for age, sex, race, and vitamin D supplementation are shown on the top of each panel. See text and table 2 for details. HY = Hoehn and Yahr; 25[OH]D = 25-hydroxy-vitamin D; PD = Parkinson disease; UPDRS = Unified Parkinson’s Disease Rating Scale.

Comment in

References

    1. Scherzer CR, Eklund AC, Morse LJ, et al. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci USA 2007;104:955–960 - PMC - PubMed
    1. Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 1997;49:1273–1278 - PubMed
    1. Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 2008;65:1348–1352 - PMC - PubMed
    1. Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol 2010;67:808–811 - PMC - PubMed
    1. Wang JY, Wu JN, Cherng TL, et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res 2001;904:67–75 - PubMed

Publication types